In vivo purging with Rituximab before autologous peripheral blood progenitor cell (PBPC) transplantation in lymphoma patients (PTS).

被引：0
|
作者：
Salles, G [1 ]
Moullet, I [1 ]
Charlot, C [1 ]
Thieblemont, C [1 ]
Bouafia, F [1 ]
Dumontet, C [1 ]
Espinouse, D [1 ]
Coiffier, B [1 ]
机构：
[1] Ctr Hosp Lyon Sud, Hematol Serv, F-69310 Pierre Benite, France
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
619
引用
收藏
页码：141A / 141A
页数：1
相关论文
共 50 条
  • [1] A model for analysing the cost of autologous peripheral blood progenitor cell (PBPC) transplantation
    Barosi, G
    Marchetti, M
    Alessandrino, P
    Locatelli, F
    Casula, S
    Lunghi, M
    Cazzola, M
    Giraldi, E
    Bernasconi, C
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 (07) : 719 - 725
  • [2] A model for analysing the cost of autologous peripheral blood progenitor cell (PBPC) transplantation
    G Barosi
    M Marchetti
    P Alessandrino
    F Locatelli
    S Casula
    M Lunghi
    M Cazzola
    E Giraldi
    C Bernasconi
    [J]. Bone Marrow Transplantation, 1999, 23 : 719 - 725
  • [3] Efficiency of in vivo purging with rituximab prior to autologous peripheral blood progenitor cell transplantation in B-cell non-Hodgkin's lymphoma:: a single institution study
    Belhadj, K
    Delfau-Larue, MH
    Elgnaoui, T
    Beaujean, F
    Beaumont, JL
    Pautas, C
    Gaillard, I
    Kirova, Y
    Allain, A
    Gaulard, P
    Farcet, JP
    Reyes, F
    Haioun, C
    [J]. ANNALS OF ONCOLOGY, 2004, 15 (03) : 504 - 510
  • [4] Ex vivo graft purging and expansion of autologous mobilized peripheral blood progenitor cell (PBPC) products from patients with multiple myeloma (MM)
    Yang, Hong
    Robinson, Simon N.
    Kieto, Yago
    Giralt, Sergio A.
    Jones, Roy B.
    Decker, William K.
    Xing, Dongxia
    Steiner, David
    Champlin, Richard E.
    Ng, Jingjing
    Thomas, Michael W.
    de Lima, Marcos
    Shpall, Elizabeth J.
    [J]. BLOOD, 2007, 110 (11) : 237A - 237A
  • [5] Autologous CD34+ enriched peripheral blood progenitor cell (PBPC) transplantation is associated with higher morbidity in patients with lymphoma when compared to unmanipulated PBPC transplantation
    J Friedman
    HM Lazarus
    ON Koç
    [J]. Bone Marrow Transplantation, 2000, 26 : 831 - 836
  • [6] Autologous CD34+ enriched peripheral blood progenitor cell (PBPC) transplantation is associated with higher morbidity in patients with lymphoma when compared to unmanipulated PBPC transplantation
    Friedman, J
    Lazarus, HM
    Koç, ON
    [J]. BONE MARROW TRANSPLANTATION, 2000, 26 (08) : 831 - 836
  • [7] Immunomagnetic bone marrow (BM) and peripheral blood progenitor cell (PBPC) purging in follicular lymphoma (FL)
    Martín-Henao, GA
    Picón, M
    Limón, A
    Carmona, M
    Amill, B
    Azqueta, C
    López, R
    González-Barca, E
    Grañena, A
    Brunet, S
    García, J
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 (06) : 579 - 587
  • [8] Immunomagnetic bone marrow (BM) and peripheral blood progenitor cell (PBPC) purging in follicular lymphoma (FL)
    GA Martín-Henao
    M Picón
    A Limón
    M Carmona
    B Amill
    C Azqueta
    R López
    E González-Barca
    A Grañena
    S Brunet
    J García
    [J]. Bone Marrow Transplantation, 1999, 23 : 579 - 587
  • [9] Peripheral blood progenitor cell (PBPC) transplantation with a single apheresis in patients with lymphoma, myeloma and solid tumors
    Efremidis, AP
    Koumakis, G
    Filis, J
    Moraki, M
    Vassilomanolakis, M
    Hatzichristou, H
    Barbounis, V
    Stamatellou, M
    Papanastasiou, K
    Kritsioti, M
    Plataniotis, G
    Arseni, P
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 1996, 57 (04) : 269 - 277
  • [10] Autologous peripheral blood progenitor cell transplantation in lymphoma patients: early outcome and cell dose
    de Paz, R
    Fernandez-Jimenez, MC
    Arrieta, R
    Canales, M
    Hernandez-Navarro, F
    [J]. BONE MARROW TRANSPLANTATION, 2003, 31 : S74 - S74
12345